Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	MK-0524B 2g/20 mg	297
Overall Study	STARTED	MK-0524B 2g/40mg	436
Overall Study	STARTED	Atorvastatin 10 mg	298
Overall Study	STARTED	Atorvastatin 20 mg	439
Overall Study	STARTED	Atorvastatin 40 mg	437
Overall Study	STARTED	Atorvastatin 80 mg	433
Overall Study	Treated	MK-0524B 2g/20 mg	297
Overall Study	Treated	MK-0524B 2g/40mg	435
Overall Study	Treated	Atorvastatin 10 mg	298
Overall Study	Treated	Atorvastatin 20 mg	439
Overall Study	Treated	Atorvastatin 40 mg	437
Overall Study	Treated	Atorvastatin 80 mg	433
Overall Study	COMPLETED	MK-0524B 2g/20 mg	229
Overall Study	COMPLETED	MK-0524B 2g/40mg	316
Overall Study	COMPLETED	Atorvastatin 10 mg	265
Overall Study	COMPLETED	Atorvastatin 20 mg	380
Overall Study	COMPLETED	Atorvastatin 40 mg	392
Overall Study	COMPLETED	Atorvastatin 80 mg	372
Overall Study	NOT COMPLETED	MK-0524B 2g/20 mg	68
Overall Study	NOT COMPLETED	MK-0524B 2g/40mg	120

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00289900/flow